6 results match your criteria: "Headache Centre and Pain Neuromodulation Unit[Affiliation]"

Central and Peripheral Neural Targets for Neurostimulation of Chronic Headaches.

Curr Pain Headache Rep

March 2017

Department of Neurology, Headache Centre and Pain Neuromodulation Unit, Fondazione Istituto Nazionale Neurologico Carlo Besta, Via Celoria 11, 20133, Milano, Italy.

Purpose Of Review: Chronic headache sufferers are estimated to be around 3% of the population. These patients have a high disease burden. When prophylactic treatments have low efficacy and tolerability, patients are in need of alternative therapeutic strategies and options.

View Article and Find Full Text PDF

Advances in the understanding of cluster headache.

Expert Rev Neurother

February 2017

a Department of Neurology, Headache Centre and Pain Neuromodulation Unit, Fondazione Istituto Nazionale Neurologico Carlo Besta , Milano , Italy.

Cluster headache is the worst primary headache form; it occurs in paroxysmal excruciatingly severe unilateral head pain attacks usually grouped in cluster periods. The familial occurrence of the disease indicates a genetic component but a gene abnormality is yet to be disclosed. Activation of trigeminal afferents and cranial parasympathetic efferents, the so-called trigemino-parasympathetic reflex, can explain pain and accompanying oculo-facial autonomic phenomena.

View Article and Find Full Text PDF

Long-term occipital nerve stimulation for drug-resistant chronic cluster headache.

Cephalalgia

July 2017

2 Department of Neurosurgery, Fondazione Istituto Nazionale Neurologico Carlo Besta, Italy.

Introduction Chronic cluster headache is rare and some of these patients become drug-resistant. Occipital nerve stimulation has been successfully employed in open studies to treat chronic drug-resistant cluster headache. Data from large group of occipital nerve stimulation-treated chronic cluster headache patients with long duration follow-up are advantageous.

View Article and Find Full Text PDF

The peripheral and central origin of pain in cluster headache (CH) and trigeminal autonomic cephalgias (TACs) has been matter of debate. In the last decade, a number of information came from both animal and human studies. This paper briefly highlights main data from these studies.

View Article and Find Full Text PDF

Success, failure, and putative mechanisms in hypothalamic stimulation for drug-resistant chronic cluster headache.

Pain

January 2013

Department of Neurology, Headache Centre and Pain Neuromodulation Unit, Fondazione Istituto Nazionale Neurologico Carlo Besta, Milano, Italy Department of Neurosurgery, Fondazione Istituto Nazionale Neurologico Carlo Besta, Milano, Italy.

Drug-resistant chronic cluster headache (CH) is an unremitting illness with excruciatingly severe headaches that occur several times daily. Starting in 2000, a total of 19 patients with long-lasting chronic CH, with multiple daily attacks unresponsive to all known prophylactics, received stimulation of the posterior inferior hypothalamic area ipsilateral to the pain as treatment. We report long-term follow-up (median 8.

View Article and Find Full Text PDF